McGill University-ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2023

  1. Evaluating the Construct of Damage in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 75, Núm. 5, pp. 998-1006

2022

  1. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the rheumatic diseases, Vol. 81, Núm. 3, pp. 370-378

  2. Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic

    Lupus Science and Medicine, Vol. 9, Núm. 1

  3. Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis Care and Research, Vol. 74, Núm. 4, pp. 638-647

  4. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 11, pp. 1541-1548

2021

  1. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

    Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1789-1795

  2. Impact of glucocorticoids on the incidence of lupus-related major organ damage: A systematic literature review and meta-regression analysis of longitudinal observational studies

    Lupus Science and Medicine, Vol. 8, Núm. 1

  3. Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: Data from an international inception cohort

    Rheumatology (United Kingdom), Vol. 60, Núm. 10, pp. 4737-4747

  4. Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception Cohort

    Arthritis and Rheumatology, Vol. 73, Núm. 12, pp. 2293-2302

2020

  1. Construction of a frailty index as a novel health measure in systemic lupus erythematosus

    Journal of Rheumatology, Vol. 47, Núm. 1, pp. 72-81

  2. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 3, pp. 356-362

  3. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 72, Núm. 1, pp. 67-77

  4. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis and Rheumatology, Vol. 72, Núm. 4, pp. 658-666

2019

  1. Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus

    Arthritis and Rheumatology, Vol. 71, Núm. 8, pp. 1297-1307

  2. Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis and Rheumatology, Vol. 71, Núm. 2, pp. 281-289

2018

  1. Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

    Arthritis Care and Research, Vol. 70, Núm. 10, pp. 1478-1487

  2. Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

    Arthritis Care and Research, Vol. 70, Núm. 1, pp. 98-103

2017

  1. Breast cancer in systemic lupus

    Lupus, Vol. 26, Núm. 3, pp. 311-315

2014

  1. Lymphoma risk in systemic lupus: Effects of disease activity versus treatment

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 138-142

2013

  1. Breast Cancer In Systemic Lupus (SLE): Do Demographic and Clinical Factors, Including DNA serology, Influence Risk?

    ARTHRITIS AND RHEUMATISM